500
Participants
Start Date
January 1, 2023
Primary Completion Date
September 15, 2025
Study Completion Date
December 15, 2025
Atherolive
The patient will be assigned using a computer-generated randomization list (1: 1 allocation). The investigator who has the randomization code is not involved in other study procedures and does not interact with participants. The study drug (atherol) will be prescribed at a dose of 400 mg, once a day for 3 months.
Placebo Atherolive
The patient will be assigned using a computer-generated randomization list (1: 1 allocation). The investigator who has the randomization code is not involved in other study procedures and does not interact with participants. The placebo will be prescribed at a dose of 400 mg once a day for 3 months.
RECRUITING
Semir Nouira, Monastir
University of Monastir
OTHER